A Glimpse into the Future of Trial Design…

In this ISSUE

What's Next for Drug Validation in the Age of Precision Medicine?

GlaxoSmithKline Tackling Data Challenges to Streamline Drug Development

Tackling the Challenges of Transitioning to Risk-Based Monitoring

Trial Troubles

The Cancer Trial Paradox – Too Few Patients to Some, Too Few Trials to Others

David M. Kronfeld, the Head of Real World Data Innovation for Medidata, writes of Mercy Hospital in Joplin, Missouri, that despite seeing over 600 new cancer patients each year, it has historically had very limited access to clinical trials.
... /Read more/

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
Europe: Thursday, June 27, 2019 at 3pm BST | 4pm CEST

News

Latest in Business and People News

Catch up on all the latest happenings in the industry from the past month.
... /Read more/

Calendar

/ 2^nd Annual Direct–to–Patient Clinical Trials – 8/8-8/9 /

/ T3: Trials, Tech, and Transformation — 8/8-8/9 /

/ 3^rd Annual Medical Writers Summit — 9/25–9/26 /

/ 4^th Annual Lay Summaries Summit — 9/25–9/26 /

Refocusing on Risk Mitigation in Starting Clinical Trials
On Demand

Learn More

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
On Demand

Learn More

European Drug Development

Still Reaching for Hearts and Minds on Drug Development Challenges

Peter O'Donnell writes about the results of a public opinion survey, the latest the European drug industry's attempts to fight back against what it sees as a climate of misunderstanding.
... /Read more/

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
On Demand

Learn More

Trial Design

Glimpsing the Future of Clinical Trial Design

A look at three contemporary trends that though integrated cautiously at first, may open up a reimagined world of clinical research.
... /Read more/

COPD – Tackling the Unmet Needs
On Demand

Learn More

Peer-Reviewed Articles

The Well-Adjusted Statistician: Analysis of Covariance Explained

How to account and adjust for covariates in clinical trial randomization–and be confident about uncertainty.
... /Read more/

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
tbaker@mmhgroup.com

website / blog / advertise / subscribe